STANDARD BIOTOOLS INC. (LAB) Net margin 2016–2025
STANDARD BIOTOOLS INC. (LAB) net profit margin by fiscal year — reported net income divided by reported revenue.
-87.8%FY2025 · since FY2016: -72.8% → -87.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -87.8% | +64.8 pp |
| FY2024 | -152.6% | -82.4 pp |
| FY2023 | -70.2% | +123.9 pp |
| FY2022 | -194.1% | -148.7 pp |
| FY2021 | -45.4% | -7.0 pp |
| FY2020 | -38.4% | +16.9 pp |
| FY2019 | -55.3% | -3.0 pp |
| FY2018 | -52.2% | +7.1 pp |
| FY2017 | -59.4% | +13.4 pp |
| FY2016 | -72.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice